Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus clonidine for prevention of postoperative delirium after major orthopedic surgery
IRCT20170316033099N7Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clonidine and melatonin in postoperative delirium (POD) (3 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoint: Delirium. Started Feb 2019; status: completed.
02
Drugs
clonidinemelatonin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on IRCT20170316033099N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170316033099N7.